Cyfuse Biomedical K.K. (4892.T)

JPY 463.0

(2.89%)

Inventory Summary of Cyfuse Biomedical K.K.

  • Cyfuse Biomedical K.K.'s latest annual inventory in 2023 was 46.04 Million JPY , up 13.98% from previous year.
  • Cyfuse Biomedical K.K.'s latest quarterly inventory in 2024 Q1 was 52.32 Million JPY , up 13.63% from previous quarter.
  • Cyfuse Biomedical K.K. reported annual inventory of 40.39 Million JPY in 2022, down -34.6% from previous year.
  • Cyfuse Biomedical K.K. reported annual inventory of 61.76 Million JPY in 2021, up 165.8% from previous year.
  • Cyfuse Biomedical K.K. reported quarterly inventory of 49.45 Million JPY for 2024 Q2, down -5.48% from previous quarter.
  • Cyfuse Biomedical K.K. reported quarterly inventory of 45.92 Million JPY for 2023 Q3, up 11.98% from previous quarter.

Annual Inventory Chart of Cyfuse Biomedical K.K. (2023 - 2020)

Historical Annual Inventory of Cyfuse Biomedical K.K. (2023 - 2020)

Year Inventory Inventory Growth
2023 46.04 Million JPY 13.98%
2022 40.39 Million JPY -34.6%
2021 61.76 Million JPY 165.8%
2020 23.23 Million JPY 0.0%

Peer Inventory Comparison of Cyfuse Biomedical K.K.

Name Inventory Inventory Difference
Pharma Foods International Co., Ltd. 6.71 Billion JPY 99.315%
Takeda Pharmaceutical Company Limited 1209.86 Billion JPY 99.996%
Sumitomo Pharma Co., Ltd. 115.35 Billion JPY 99.96%
Shionogi & Co., Ltd. 64.91 Billion JPY 99.929%
Wakamoto Pharmaceutical Co.,Ltd. 2 Billion JPY 97.705%
Nippon Shinyaku Co., Ltd. 39.11 Billion JPY 99.882%
Kaken Pharmaceutical Co., Ltd. 17.16 Billion JPY 99.732%
Eisai Co., Ltd. 174.65 Billion JPY 99.974%
Morishita Jintan Co., Ltd. 3.18 Billion JPY 98.554%
Hisamitsu Pharmaceutical Co., Inc. 21.17 Billion JPY 99.783%
Mochida Pharmaceutical Co., Ltd. 30.27 Billion JPY 99.848%
Fuso Pharmaceutical Industries,Ltd. 14.2 Billion JPY 99.676%
Nippon Chemiphar Co., Ltd. 10.72 Billion JPY 99.571%
Tsumura & Co. 117.61 Billion JPY 99.961%
Kissei Pharmaceutical Co., Ltd. 26.29 Billion JPY 99.825%
Torii Pharmaceutical Co., Ltd. 10.74 Billion JPY 99.571%
Towa Pharmaceutical Co., Ltd. 101.07 Billion JPY 99.954%
Fuji Pharma Co., Ltd. 19.37 Billion JPY 99.762%
Zeria Pharmaceutical Co., Ltd. 14.48 Billion JPY 99.682%
KYORIN Holdings, Inc. 53.47 Billion JPY 99.914%
Taiko Pharmaceutical Co.,Ltd. 1.95 Billion JPY 97.641%
Daito Pharmaceutical Co.,Ltd. 20.89 Billion JPY 99.78%
SymBio Pharmaceuticals Limited 232.03 Million JPY 80.156%
MedRx Co., Ltd 10 Million JPY -360.45%
Mizuho Medy Co.,Ltd. 1.59 Billion JPY 97.116%
Solasia Pharma K.K. 122 Million JPY 62.258%
Modalis Therapeutics Corporation 6.35 Million JPY -624.776%
ASKA Pharmaceutical Holdings Co.,Ltd. 20.4 Billion JPY 99.774%
Sawai Group Holdings Co., Ltd. 100 Billion JPY 99.954%
Toho Holdings Co., Ltd. 87.28 Billion JPY 99.947%
Koa Shoji Holdings Co.,Ltd. 2.26 Billion JPY 97.968%